Serotype distribution of remaining pneumococcal meningitis in the mature PCV10/13 period: findings from the PSERENADE Project Read more about Serotype distribution of remaining pneumococcal meningitis in the mature PCV10/13 period: findings from the PSERENADE Project14 views
Changes in serotype 1 invasive pneumococcal disease following introduction of PCV10 and PCV13: findings from the PSERENADE Project Read more about Changes in serotype 1 invasive pneumococcal disease following introduction of PCV10 and PCV13: findings from the PSERENADE Project14 views
Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in Australia Read more about Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in Australia26 views
An outbreak of serotype-1 sequence type 306 invasive pneumococcal disease in an Australian Indigenous population Read more about An outbreak of serotype-1 sequence type 306 invasive pneumococcal disease in an Australian Indigenous population22 views
Meningococcal and pneumococcal carriage in Hajj pilgrims: findings of a randomized controlled trial Read more about Meningococcal and pneumococcal carriage in Hajj pilgrims: findings of a randomized controlled trial66 views
Long-term impact of pneumococcal conjugate vaccines on invasive disease and pneumonia hospitalizations in Indigenous and non-Indigenous Australians Read more about Long-term impact of pneumococcal conjugate vaccines on invasive disease and pneumonia hospitalizations in Indigenous and non-Indigenous Australians22 views
Pneumococcal vaccination uptake among patients aged 65 years or over in Australian general practice Read more about Pneumococcal vaccination uptake among patients aged 65 years or over in Australian general practice49 views
Pneumococcal vaccination uptake among patients aged 65 years or over in Australian general practice Read more about Pneumococcal vaccination uptake among patients aged 65 years or over in Australian general practice48 views
Reply to letter: Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia Read more about Reply to letter: Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia34 views
What isn’t measured isn’t done – eight years with no progress in Aboriginal and Torres Strait Islander adult influenza and pneumococcal vaccination Read more about What isn’t measured isn’t done – eight years with no progress in Aboriginal and Torres Strait Islander adult influenza and pneumococcal vaccination88 views
